Evidence map›Paper›PMID 36678157›Full record

Trial reportNutrients2023

Astaxanthin Supplemented with High-Intensity Functional Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity.

Ayoub Saeidi, Akbar Nouri-Habashi, Omid Razi, Ali Ataeinosrat, Hiwa Rahmani, Shirin Shirzad Mollabashi, Behnam Bagherzadeh-Rahmani, Shahin Mahmoudi Aghdam, Leila Khalajzadeh, Maisa Hamed Al Kiyumi and 4 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 7 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 7 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 13 institutions in 6 countries.

Ayoub SaeidiDepartment of Physical Education and Sport Sciences, Faculty of Humanities and Social Sciences, University of Kurdistan, Sanandaj 66177-15175, Iran.ORCID 0000-0003-2458-6256
Akbar Nouri-HabashiDepartment of Exercise Physiology and Corrective Movements, Faculty of Sport Sciences, Urmia University, Urmia 57561-51818, Iran.ORCID 0000-0002-7102-9340
Omid RaziDepartment of Exercise Physiology, Faculty of Physical Education and Sports Science, Razi University, Kermanshah 94Q5+6G3, Iran.ORCID 0000-0002-6364-7309
Ali AtaeinosratDepartment of Physical Education and Sport Science, Science and Research Branch, Islamic Azad University, Tehran 14778-93855, Iran.
Hiwa RahmaniFaculty of Physical Education and Sports Science, Alzahra University, Tehran 19938 93973, Iran.ORCID 0000-0002-0202-7384
Shirin Shirzad MollabashiFaculty of Sport Sciences, Atatürk University, Erzurum 25030, Turkey.
Behnam Bagherzadeh-RahmaniDepartment of Exercise Physiology, Faculty of Sport Sciences, Hakim Sabzevari University, Sabzevar M3J+373, Iran.
Shahin Mahmoudi AghdamDepartment of Exercise Physiology, Central Tehran Branch, Islamic Azad University, Tehran 14778-93855, Iran.
Leila KhalajzadehDepartment of Exercise Physiology, Central Tehran Branch, Islamic Azad University, Tehran 14778-93855, Iran.
Maisa Hamed Al KiyumiDepartment of Family Medicine and Public Health, Sultan Qaboos University Hospital, Muscat H5QC+36M, Oman.ORCID 0000-0001-7500-4995
Anthony C HackneyDepartment of Exercise & Sport Science, University of North Carolina, Chapel Hill, NC 27599, USA.
Ismail LaherDepartment of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada.ORCID 0000-0002-3917-4417
Katie M HeinrichDepartment of Kinesiology, College of Health and Human Sciences, Kansas State University, Manhattan, KS 66506, USA.ORCID 0000-0002-6837-408X
Hassane ZouhalLaboratoire Mouvement, Sport, Santé, University of Rennes, M2S-EA 1274, 35000 Rennes, France.ORCID 0000-0001-6743-6464
Islamic Azad University Central Tehran Branch · IRAlzahra University · IRAtatürk University · TRHakim Sabzevari University · IRIslamic Azad University, Science and Research Branch · IRKansas State University · USLaboratoire Mouvement Sport Santé · FRRazi University · IRSultan Qaboos University Hospital · OMUniversity of British Columbia · CAUniversity of Kurdistan · IRUniversity of North Carolina at Chapel Hill · USUrmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the effects of 12 weeks of high-intensity training with astaxanthin supplementation on adipokine levels, insulin resistance and lipid profiles in males with obesity. Sixty-eight males with obesity were randomly stratified into four groups of seventeen subjects each: control group (CG), supplement group (SG), training group (TG), and training plus supplement group (TSG). Participants underwent 12 weeks of treatment with astaxanthin or placebo (20 mg/d capsule daily). The training protocol consisted of 36 sessions of high-intensity functional training (HIFT), 60 min/sessions, and three sessions/week. Metabolic profiles, body composition, anthropometrical measurements, cardio-respiratory indices and adipokine [Cq1/TNF-related protein 9 and 2 (CTRP9 and CTRP2) levels, and growth differentiation factors 8 and 15 (GDF8 and GDF15)] were measured. There were significant differences for all indicators between the groups (p < 0.05). Post-hoc analysis indicated that the levels of CTRP9, CTRP2, and GDF8 were different from CG (p < 0.05), although levels of GDF15 were similar to CG (p > 0.05). Levels of GDF8 were similar in the SG and TG groups (p > 0.05), with reductions of GDF15 levels in both training groups (p < 0.05). A total of 12 weeks of astaxanthin supplementation and exercise training decreased adipokines levels, body composition (weight, %fat), anthropometrical factors (BMI), and improved lipid and metabolic profiles. These benefits were greater for men with obesity in the TSG group.

Indexed as

Cardiovascular DiseasesHigh-Intensity Interval TrainingAdipokinesBody CompositionDietary SupplementsHeart Disease Risk FactorsHumansLipidsMaleObesityRisk FactorsXanthophyllsAdipokinesastaxanthineLipidsXanthophyllsadipokinesastaxanthincardiovascular risk factorshigh-intensity trainingobesity

Identifiers

PMID36678157
PMCPMC9866205
OpenAlexW4313641123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.